This report contains market size and forecasts of Pulmonary/ Respiratory Drug Delivery in Global, including the following market information:
Global Pulmonary/ Respiratory Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pulmonary/ Respiratory Drug Delivery market was valued at 32470 million in 2021 and is projected to reach US$ 41390 million by 2028, at a CAGR of 3.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Suspension Aerosol Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary/ Respiratory Drug Delivery include Merck, Teva Pharmaceutical, 3M, Astrazeneca, Boehringer Ingelheim, Cipla, Glaxosmithkline, Novartis and Omron Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary/ Respiratory Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary/ Respiratory Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Global Pulmonary/ Respiratory Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Hospitals
Home Care
Global Pulmonary/ Respiratory Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pulmonary/ Respiratory Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary/ Respiratory Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pulmonary/ Respiratory Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Pharmaceutical
3M
Astrazeneca
Boehringer Ingelheim
Cipla
Glaxosmithkline
Novartis
Omron Corporation
Sunovion Pharmaceuticals